|
|
|
40
|
11311
|
APO-ATORVASTATIN 10MG TAB (APO/COL)
|
ATORVASTATIN
|
APO-ATORVASTATIN
|
100'S
|
A
|
4.92
|
0.05
|
TABLET
|
30
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
40
|
1131AY
|
ATORVASTATIN 10MG TAB (CPP/COL)
|
ATORVASTATIN
|
ATORVASTATIN
|
28'S
|
A
|
1.06
|
0.04
|
TABLET
|
30
|
TAB
|
CPP
|
WOCKHARDT UK LTD
|
COL
|
COLLINS LTD
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
40
|
1131CZ
|
LIPITOR 10MG TAB (PFI/STO) ATORVASTATIN
|
ATORVASTATIN
|
LIPITOR
|
30'S
|
C
|
33.19
|
1.11
|
TABLET
|
0
|
TAB
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
1131CZ
|
LIPITOR 10MG TAB (PFI) ATORVASTATIN (C)
|
ATORVASTATIN
|
LIPITOR
|
30'S
|
C
|
33.49
|
1.1163
|
TAB
|
30
|
BOX
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
|
|
|
|
40
|
1131DA
|
LIPITOR 10MG TAB (PFI/SBI) ATORVASTATIN
|
ATORVASTATIN
|
LIPITOR
|
30'S
|
C
|
33.19
|
1.11
|
TABLET
|
0
|
TAB
|
PFI
|
PFIZER CORPORATION
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
1131DA
|
LIPITOR 10MG TAB (PFI) ATORVASTATIN (C)
|
ATORVASTATIN
|
LIPITOR
|
30'S
|
C
|
33.49
|
1.1163
|
TAB
|
30
|
BOX
|
PFI
|
PFIZER CORPORATION
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
|
|
|
|
40
|
1131DQ
|
ATOREC 10MG TAB (EMC/COL) ATORVASTATIN
|
ATORVASTATIN
|
ATOREC
|
30'S
|
C
|
3.26
|
0.11
|
TABLET
|
0
|
TAB
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
1131DW
|
ATORSTAN 10MG TAB (REM) ATORVASTATI
|
ATORVASTATIN
|
ATORSTAN
|
3x10
|
A
|
1.6
|
0.0535
|
TAB
|
30
|
BOX
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2024-04-01
|
2024-06-30
|
|
ORAL
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
2024-03-25
|
|
|
|
41
|
1131DW
|
ATORSTAN 10MG TAB (REM) ATORVASTATI
|
ATORVASTATIN
|
ATORSTAN
|
3x10
|
A
|
4.78
|
0.1593
|
TAB
|
30
|
BOX
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2024-08-07
|
2024-09-18
|
|
ORAL
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
2024-08-07
|
|
|
|
41
|
1131FA
|
ATOREM 10MG TAB (MSN) ATORVASTATIN
|
ATORVASTATIN
|
ATOREM
|
3X10
|
A
|
1.2
|
0.0399
|
TAB
|
30
|
BOTT
|
MSN
|
MSN LABS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
|
|
|
|
40
|
1131FK
|
ATORVASTATIN 10MG TAB (UME/AHI)
|
ATORVASTATIN
|
ATORVASTATIN
|
3X10
|
A
|
1.44
|
0.05
|
TABLET
|
30
|
TAB
|
UME
|
UMEDICA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
1131FN
|
ATORVASTATIN 10MG TAB (TPP)
|
ATORVASTATIN
|
ATORVASTATIN
|
10X10
|
A
|
3.86
|
0.0386
|
TAB
|
30
|
BOX
|
TPP
|
THERDOSE PHARMA PRIVATE LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
2023-10-27
|
|
|
|
40
|
1131FW
|
LIPITAS 10MG TAB (INP/AHI) ATORVASTATIN
|
ATORVASTATIN
|
LIPITAS
|
30'S
|
A
|
3.56
|
0.1187
|
TABLET IMMED
|
|
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2023-03-20
|
2024-03-31
|
Add to Contract as Cat A
|
Oral
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
2023-01-04
|
|
|
|
41
|
1131FZ
|
XTOR 10MG TAB (IPC) ATORVASTATIN
|
ATORVASTATIN
|
XTOR
|
100'S
|
A
|
3.97
|
0.0397
|
TAB
|
30
|
BOX
|
IPC
|
IPCA Laboratories Ltd.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
|
|
|
|
41
|
1131GT
|
ATORVASTATIN 10MG TAB (INP)
|
ATORVASTATIN
|
ATORVASTATIN
|
1000'S
|
A
|
35.96
|
0.036
|
TAB
|
30
|
BOTT
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
|
|
|
|
40
|
1132BE
|
ATORVASTATIN 20MG TAB (CPP/COL)
|
ATORVASTATIN
|
ATORVASTATIN
|
28'S
|
A
|
1.50
|
0.05
|
TABLET
|
30
|
TAB
|
CPP
|
WOCKHARDT UK LTD
|
COL
|
COLLINS LTD
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
40
|
1132DV
|
LIPITOR 20MG TAB (PFI/STO) ATORVASTATIN
|
ATORVASTATIN
|
LIPITOR
|
30'S
|
C
|
36.21
|
1.21
|
TABLET
|
0
|
TAB
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
1132DV
|
LIPITOR 20MG TAB (PFI) ATORVASTATIN (C)
|
ATORVASTATIN
|
LIPITOR
|
30'S
|
C
|
36.53
|
1.2178
|
TAB
|
30
|
BOX
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
|
|
|
|
40
|
1132DW
|
LIPITOR 20MG TAB (PFI/SBI) ATORVASTATIN
|
ATORVASTATIN
|
LIPITOR
|
30'S
|
C
|
36.21
|
1.21
|
TABLET
|
0
|
TAB
|
PFI
|
PFIZER CORPORATION
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
1132DW
|
LIPITOR 20MG TAB (PFI) ATORVASTATIN (C)
|
ATORVASTATIN
|
LIPITOR
|
30'S
|
C
|
36.53
|
1.2178
|
TAB
|
30
|
BOX
|
PFI
|
PFIZER CORPORATION
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
|